APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study

1 September 2019 (11:00 - 11:18)
Organised by:
Congress Presentation Part of: Late Breaking Science in Atrial Fibrillation 2 Prevention ESC Premium Access ESC Congress 2019